D-1544-2020 Class II Terminated

Recalled by BAYSHORE PHARMACEUTICALS — Short Hills, NJ

FDA drug recall D-1544-2020 was initiated by BAYSHORE PHARMACEUTICALS on Aug 19, 2020 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Apr 26, 2021). Affected quantity: 3984 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 2, 2020
Initiation Date
Aug 19, 2020
Termination Date
Apr 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3984 bottles

Product description

Metformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by: Beximco Pharmaceuticals, LTD. 126, Kathaldia, Tongi, Gazipur, 1711, Bangladesh NDC 76385-129-01

Reason for recall

CGMP Deviations

Distribution pattern

nationwide

Code information

Lot #18657, Exp. 05/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1544-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1544-2020. Report a data issue: hello@regdatalab.com.